…improving nature’s own defense mechanisms
Latest releases
Jun 6, 2017:
HalioDx SAS, an immuno-oncology diagnostic company, presented Phase I data on LTX-315 at ASCO
Jun 5, 2017:
ASCO 2017 - Lytix Biopharma featured in Dagens Medisin
May 31, 2017:
Lytix Biopharma will present poster at ASCO Monday June 5t 2017
May 24, 2017:
Lytix Biopharma held company presentation at BioEquity Europe in Paris